Medical News Feed
German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Pyrrolidone derivatives (anti- epileptics /anticonvulsants). |
| Generic Name : | Levetiracetam |
| Drug description : | 250mg, blue, oblong tablets marked with "ucb 250" on one side; 500mg, yellow, oblong tablets marked with "ucb 500" on one side; white, oblong tablets marked with "ucb 1000" on one side. All film-coated tablets. |
| Presentation : | Tablets, levetiracetam 250mg , 500mg , 1000mg . |
| Indications : | Indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in patients with epilepsy. |
| Adult Dosage : | Initially, 500mg twice daily. Depending on clinical response and tolerance, daily dose can be increased up to 1,500mg twice daily. Dose changes can be made in 500mg twice daily increments or decrements every two to four weeks. Tablets can be taken with or without food. |
| Child Dosage : | Under 16 years, not recommended; Under 16 years, not recommended; over 16 years, as for adults. |
| Contra Indications : | Hypersensitivity to levetiracetam or other pyrrolidone derivatives or any of the excipients. Lactation. |
| Special Precautions : | Withdrawal of therapy should be gradual. Renal impairment - dose should be adjusted according to the degree of impairment (refer to Summary of Product Characteristics). Severe hepatic impairment. Pregnancy. |
| Interactions : | Refer to Summary of Product Characteristics. |
| Adverse Reactions : | Most commonly, somnolence, asthenia, dizziness. Also, accidental injury, headache, anorexia, diarrhoea, dyspepsia, nausea, amnesia, ataxia, convulsion, depression, emotional lability, hostility, insomnia, nervousness, tremor, vertigo, rash, diplopia. |
| Manufacturer : | UCB |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org